This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alfano, M.
Right arrow Articles by Bukrinsky, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alfano, M.
Right arrow Articles by Bukrinsky, M.

 Previous Article  |  Next Article 

Journal of Virology, September 2000, p. 8767-8770, Vol. 74, No. 18
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

The B-Oligomer of Pertussis Toxin Inhibits Human Immunodeficiency Virus Type 1 Replication at Multiple Stages

Massimo Alfano,1,2 Tatiana Pushkarsky,1 Guido Poli,2 and Michael Bukrinsky1,*

The Picower Institute for Medical Research, Manhasset, New York 11030,1 and AIDS Immunopathogenesis Unit, San Raffaele Scientific Institute, 20132 Milano, Italy2

Received 28 December 1999/Accepted 8 June 2000

We have recently demonstrated that the binding subunit (B-oligomer) of pertussis toxin (PTX-B) deactivates CCR5 and inhibits entry of R5 human immunodeficiency virus type 1 (HIV-1) strains in activated primary T lymphocytes (M. Alfano et al., J. Exp. Med. 190:597-605, 1999). We now present evidence that PTX-B also affects a postentry step of HIV-1 replication. While PTX-B inhibited fusion induced by R5 but not that induced by X4 envelopes, it blocked infection of T cells with recombinant HIV-1 particles pseudotyped with R5, X4, and even murine leukemia virus or vesicular stomatitis virus envelopes. It also suppressed HIV-1 RNA synthesis in cultures of infected peripheral blood mononuclear cells when new infections had been inhibited by zidovudine, and it reduced Tat-dependent expression of the luciferase reporter gene controlled by the HIV-1 long terminal repeat (LTR). Surprisingly, PTX-B did not affect expression from the cytomegalovirus promoter, nor did it reduce the basal (Tat-independent) expression from the LTR promoter. These results indicate that PTX-B inhibits HIV-1 infection at both the entry and the postentry stages of viral replication, with the postentry activity specifically affecting transcription or stability of Tat-stimulated HIV-1 mRNAs.


* Corresponding author. Mailing address: The Picower Institute for Medical Research, 350 Community Dr., Manhasset, NY 11030. Phone: (516) 562-9438. Fax: (516) 365-0286. E-mail: mbukrinsky{at}picower.edu.


Journal of Virology, September 2000, p. 8767-8770, Vol. 74, No. 18
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Schneider, O. D., Weiss, A. A., Miller, W. E. (2009). Pertussis Toxin Signals through the TCR to Initiate Cross-Desensitization of the Chemokine Receptor CXCR4. J. Immunol. 182: 5730-5739 [Abstract] [Full Text]  
  • Rizzi, C., Crippa, M. P., Jeeninga, R. E., Berkhout, B., Blasi, F., Poli, G., Alfano, M. (2006). Pertussis Toxin B-Oligomer Suppresses IL-6 Induced HIV-1 and Chemokine Expression in Chronically Infected U1 Cells via Inhibition of Activator Protein 1. J. Immunol. 176: 999-1006 [Abstract] [Full Text]  
  • Zocchi, M. R., Contini, P., Alfano, M., Poggi, A. (2005). Pertussis Toxin (PTX) B Subunit and the Nontoxic PTX Mutant PT9K/129G Inhibit Tat-Induced TGF-{beta} Production by NK Cells and TGF-{beta}-Mediated NK Cell Apoptosis. J. Immunol. 174: 6054-6061 [Abstract] [Full Text]  
  • Lapenta, C., Spada, M., Santini, S. M., Racca, S., Dorigatti, F., Poli, G., Belardelli, F., Alfano, M. (2005). Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice. Int Immunol 17: 469-475 [Abstract] [Full Text]  
  • Su, S. B., Silver, P. B., Wang, P., Chan, C.-C., Caspi, R. R. (2003). Dissociating the Enhancing and Inhibitory Effects of Pertussis Toxin on Autoimmune Disease. J. Immunol. 171: 2314-2319 [Abstract] [Full Text]  
  • Lin, Y.-L., Mettling, C., Portales, P., Reynes, J., Clot, J., Corbeau, P. (2002). Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection. Proc. Natl. Acad. Sci. USA 99: 15590-15595 [Abstract] [Full Text]  
  • Alfano, M., Vallanti, G., Biswas, P., Bovolenta, C., Vicenzi, E., Mantelli, B., Pushkarsky, T., Rappuoli, R., Lazzarin, A., Bukrinsky, M., Poli, G. (2001). The Binding Subunit of Pertussis Toxin Inhibits HIV Replication in Human Macrophages and Virus Expression in Chronically Infected Promonocytic U1 Cells. J. Immunol. 166: 1863-1870 [Abstract] [Full Text]  
  • Percherancier, Y., Planchenault, T., Valenzuela-Fernandez, A., Virelizier, J.-L., Arenzana-Seisdedos, F., Bachelerie, F. (2001). Palmitoylation-dependent Control of Degradation, Life Span, and Membrane Expression of the CCR5 Receptor. J. Biol. Chem. 276: 31936-31944 [Abstract] [Full Text]